Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceuticals ranked by total liabilities, at CZK 203.6M, followed by Belite Bio (CZK 223.9M) and Oruka Therapeutics (CZK 371M). Figures as of 18 Nov 2026, 16:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsCZK 203.6M
- Median
- CZK 46.3B
- Combined market value
- CZK 113.09T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | CZK 203.6M | CZK 117B | CZK 2,773.85 | 0.71% down | 233% up | ||
| 2 | Belite BioBLTE · Health Care | CZK 223.9M | CZK 143.7B | CZK 3,538.97 | 0.91% up | 31% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | CZK 371M | CZK 145.8B | CZK 2,149.04 | 0.34% up | 241% up | ||
| 4 | Edgewise TherapeuticsEWTX · Health Care | CZK 674.8M | CZK 99.3B | CZK 906.70 | 3.00% down | 88% up | ||
| 5 | Dianthus TherapeuticsDNTH · Health Care | CZK 834.3M | CZK 108.2B | CZK 1,921.91 | 0.63% down | 113% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | CZK 1.2B | CZK 180.9B | CZK 2,771.85 | 0.01% down | 46% up | ||
| 7 | Praxis Precision MedicinesPRAX · Health Care | CZK 1.3B | CZK 189.8B | CZK 6,790.22 | 0.10% up | 61% up | ||
| 8 | Spyre TherapeuticsSYRE · Health Care | CZK 1.4B | CZK 200.9B | CZK 2,115.02 | 1.40% up | 286% up | ||
| 9 | ErascaERAS · Health Care | CZK 1.6B | CZK 103.4B | CZK 294.62 | 4.61% down | 403% up | ||
| 10 | Summit TherapeuticsSMMT · Health Care | CZK 2.1B | CZK 192.9B | CZK 241.25 | 1.69% up | 36% down | ||
| 11 | Definium TherapeuticsDFTX · Health Care | CZK 2.4B | CZK 86.7B | CZK 633.48 | 3.03% down | 169% up | ||
| 12 | ABIVAXABVX · Health Care | CZK 3.2B | CZK 162.8B | CZK 1,859.87 | 1.88% up | 27% down | ||
| 13 | Corcept TherapeuticsCORT · Health Care | CZK 4.2B | CZK 167.1B | CZK 1,526.79 | 2.01% down | 8% down | ||
| 14 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CZK 4.4B | CZK 168.1B | CZK 2,139.93 | 1.19% up | 126% up | ||
| 15 | Rhythm PharmaceuticalsRYTM · Health Care | CZK 4.7B | CZK 179.9B | CZK 2,594.53 | 0.06% up | 13% up | ||
| 16 | Cogent BiosciencesCOGT · Health Care | CZK 6.7B | CZK 110.7B | CZK 636.01 | 2.71% up | 20% down | ||
| 17 | TG TherapeuticsTGTX · Health Care | CZK 9.2B | CZK 215.4B | CZK 1,425.06 | 2.20% up | 107% up | ||
| 18 | Roivant SciencesROIV · Health Care | CZK 9.3B | CZK 625.7B | CZK 863.62 | 0.34% up | 90% up | ||
| 19 | Travere TherapeuticsTVTX · Health Care | CZK 10.9B | CZK 107.4B | CZK 1,118.66 | 1.55% down | 44% up | ||
| 20 | Mirum PharmaceuticalsMIRM · Health Care | CZK 11.7B | CZK 132.9B | CZK 2,036.42 | 0.40% down | 31% up | ||
| 21 | Ligand PharmaceuticalsLGND · Health Care | CZK 12.1B | CZK 133.3B | CZK 6,664.92 | 2.02% up | 43% up | ||
| 22 | Axsome TherapeuticsAXSM · Health Care | CZK 13.4B | CZK 156.2B | CZK 2,970.41 | 1.74% down | 7% down | ||
| 23 | Madrigal PharmaceuticalsMDGL · Health Care | CZK 14.6B | CZK 212.7B | CZK 9,157.16 | 2.41% down | 24% down | ||
| 24 | AlkermesALKS · Health Care | CZK 14.8B | CZK 174.3B | CZK 1,037.50 | 2.66% up | 58% up | ||
| 25 | Legend BiotechLEGN · Health Care | CZK 16.3B | CZK 69.9B | CZK 360.55 | 0.65% up | 42% down | ||
| 26 | United TherapeuticsUTHR · Health Care | CZK 17.4B | CZK 543.9B | CZK 12,770.07 | 1.68% down | 23% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | CZK 19.6B | CZK 136.6B | CZK 966.12 | 1.07% up | 10% up | ||
| 28 | BioMarin PharmaceuticalBMRN · Health Care | CZK 33.5B | CZK 259.2B | CZK 1,338.34 | 2.87% up | 11% up | ||
| 29 | InsmedINSM · Health Care | CZK 33.9B | CZK 585.4B | CZK 2,668.46 | 1.52% down | 40% down | ||
| 30 | Ascendis PharmaASND · Health Care | CZK 36.2B | CZK 394.5B | CZK 6,013.76 | 0.27% down | 28% up | ||
| 31 | CytokineticsCYTK · Health Care | CZK 46.3B | CZK 158.8B | CZK 1,139.78 | 0.76% down | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | CZK 47.1B | CZK 277.8B | CZK 333.20 | 1.32% up | 5% up | ||
| 33 | BridgeBio PharmaBBIO · Health Care | CZK 67B | CZK 337.6B | CZK 1,733.30 | 1.50% up | 17% up | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | CZK 67.5B | CZK 101B | CZK 606.58 | 1.19% up | 64% down | ||
| 35 | PTC TherapeuticsPTCT · Health Care | CZK 69B | CZK 112.5B | CZK 1,346.35 | 0.31% up | 20% down | ||
| 36 | Amneal PharmaceuticalsAMRX · Health Care | CZK 81.7B | CZK 167.5B | CZK 480.73 | 2.37% up | 83% up | ||
| 37 | BeOne MedicinesONC · Health Care | CZK 85.1B | CZK 1.03T | CZK 8,995.74 | 2.10% down | 17% up | ||
| 38 | Alnylam PharmaceuticalsALNY · Health Care | CZK 92.9B | CZK 456.6B | CZK 3,409.23 | 2.03% down | 66% down | ||
| 39 | Elanco Animal HealthELAN · Health Care | CZK 151.4B | CZK 293.6B | CZK 587.46 | 2.21% up | 20% up | ||
| 40 | Vertex PharmaceuticalsVRTX · Health Care | CZK 155.1B | CZK 3.02T | CZK 11,894.11 | 0.13% up | 27% up | ||
| 41 | GenmabGMAB · Health Care | CZK 156.2B | CZK 705.4B | CZK 1,144.01 | 0.98% down | 70% up | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | CZK 163.2B | CZK 347.9B | CZK 5,420.30 | 1.27% up | 37% up | ||
| 43 | Regeneron PharmaceuticalsREGN · Health Care | CZK 206.8B | CZK 2.2T | CZK 21,250.05 | 0.22% down | 36% up | ||
| 44 | Royalty PharmaRPRX · Health Care | CZK 220.3B | CZK 876.3B | CZK 1,524.01 | 0.20% down | 78% up | ||
| 45 | ZoetisZTS · Health Care | CZK 269.8B | CZK 758.4B | CZK 1,866.54 | 0.56% up | 29% down | ||
| 46 | GrifolsGRFS · Health Care | CZK 298.7B | CZK 129.5B | CZK 190.22 | 0.87% down | 1% up | ||
| 47 | ViatrisVTRS · Health Care | CZK 499.9B | CZK 528.6B | CZK 461.05 | 1.39% up | 96% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | CZK 730.1B | CZK 1.1T | CZK 943.22 | 0.47% down | 74% up | ||
| 49 | Abbott LaboratoriesABT · Health Care | CZK 754.7B | CZK 4.01T | CZK 2,315.47 | 0.55% down | 17% down | ||
| 50 | Takeda PharmaceuticalTAK · Health Care | CZK 1.13T | CZK 1.52T | CZK 475.28 | 1.22% down | 54% up | ||
| 51 | Novo NordiskNVO · Health Care | CZK 1.15T | CZK 3.9T | CZK 883.96 | 2.32% down | 17% down | ||
| 52 | GSKGSK · Health Care | CZK 1.33T | CZK 2.18T | CZK 1,086.64 | 0.75% down | 6% up | ||
| 53 | SanofiSNY · Health Care | CZK 1.36T | CZK 2.52T | CZK 1,051.51 | 0.50% down | 4% down | ||
| 54 | NovartisNVS · Health Care | CZK 1.43T | CZK 6.56T | CZK 3,475.60 | 1.77% down | 25% up | ||
| 55 | AstraZenecaAZN · Health Care | CZK 1.45T | CZK 6.18T | CZK 3,981.56 | 1.76% down | 2% up | ||
| 56 | Bristol-Myers SquibbBMY · Health Care | CZK 1.59T | CZK 2.72T | CZK 1,331.89 | 2.36% down | 34% up | ||
| 57 | Merck & CoMRK · Health Care | CZK 1.87T | CZK 7.65T | CZK 3,103.83 | 2.64% down | 51% up | ||
| 58 | Eli LillyLLY · Health Care | CZK 1.91T | CZK 27.52T | CZK 30,892.39 | 1.85% down | 35% up | ||
| 59 | Johnson & JohnsonJNJ · Health Care | CZK 2.62T | CZK 14.73T | CZK 6,118.93 | 1.26% down | 38% up | ||
| 60 | PfizerPFE · Health Care | CZK 2.7T | CZK 3.57T | CZK 626.48 | 1.04% down | 14% up | ||
| 61 | AbbVieABBV · Health Care | CZK 3.05T | CZK 11.34T | CZK 6,412.99 | 1.50% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2353 CZK).
Questions and answers
Which pharmaceuticals have the lowest total liabilities?
Veradermics (CZK 203.6M), Belite Bio (CZK 223.9M) and Oruka Therapeutics (CZK 371M) have the lowest total liabilities of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of CZK 113.09T as of 18 Nov 2026, 16:06 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.